dr. liu on the checkmate-032 trial in sclc
Published 4 years ago • 177 plays • Length 1:44Download video MP4
Download video MP3
Similar videos
-
1:23
dr. liu on the potential of pembrolizumab in sclc
-
1:32
dr. spigel on checkmate-331 trial for sclc
-
1:16
dr. ott on the checkmate-032 study in gastric and gej cancer
-
5:56
results from checkmate-032, nivolumab and ipilimumab for melanoma
-
0:52
dr. hellmann on the design of the checkmate-032 study for lung cancer
-
5:19
second chances with bcma second line therapy | #myeloma
-
4:10
when to use the checkmate-227 regimen
-
17:38
2020 stat115 lect22.3 tumor immune deconvolution
-
1:32
dr. liu on alk-targeted agents in nsclc
-
2:09
checkmate 032: nivolumab/ipilimumab for urothelial carcinoma
-
1:59
dr. lai on the results of the caspian trial in small cell lung cancer
-
1:30
dr. feliciano on nivolumab in small cell lung cancer
-
2:17
dr. borghaei on the checkmate-227 trial in nsclc
-
6:07
interpreting the results of checkmate-227 in nsclc
-
5:06
impower133 in sclc
-
1:02
dr. hellmann on nivolumab in combination with ipilimumab for small cell lung cancer
-
1:05
dr. liu on sequencing therapy in alk-positive nsclc
-
1:29
dr. kelly on the toxicity profile in checkmate-227 in nsclc
-
2:04
george simon, md, facp, fccp, on the checkmate 032 & ctong 1104 nsclc studies presented at asco
-
0:51
dr. chiang on toxicities with ipilimumab plus nivolumab in small cell lung cancer
-
1:22
dr. reck on safety data from the checkmate-9la trial in metastatic/recurrent nsclc
-
10:46
the checkmate 9la trial for stage iv/recurrent non-small cell lung cancer